Published April 2, 2026 | Version v1
Computational notebook Open

Data and Code for: The temperature dependence of amyloid β solubility reveals the hydrophobic effect as the main driving force for fibril formation

Authors/Creators

  • 1. Lund University
  • 2. ROR icon Karolinska Institutet
  • 3. ROR icon KTH Royal Institute of Technology

Files

Lindberg_etal_2026_PNAS-main.zip

Files (64.1 MB)

Name Size Download all
md5:8a5fdcd84f4586e1e8880e776350780b
64.1 MB Preview Download

Additional details

Identifiers

URL
https://github.com/saralinse/Published_Data/tree/PNAS_2026_tempdep_amyloid_solubility

Related works

Is described by
Thesis: 978-91-8096-075-5 (ISBN)

Dates

Accepted
2026-03-27

Software

Repository URL
https://github.com/saralinse/Published_Data/tree/PNAS_2026_tempdep_amyloid_solubility
Programming language
Python

References

  • References 1. CM Dobson, Protein folding and misfolding. Nature 426, 884–890 (2003). 2. D Willbold, B Strodel, GF Schr ¨oder, W Hoyer, H Heise, Amyloid-type Protein Aggregation and Prion-like Properties of Amyloids. Chem. Rev. 121, 8285–8307 (2021). 3. YL Lyubchenko, AV Krasnoslobodtsev, S Luca, Fibrillogenesis of Huntingtin and Other Glutamine Containing Proteins. Sub-cellular biochemistry 65, 225–251 (2012). 4. T Wiegand, et al., Asparagine and Glutamine Side-Chains and Ladders in HET-s(218–289) Amyloid Fibrils Studied by Fast Magic-Angle Spinning NMR. Front. Mol. Biosci. 7, 582033 (2020). 5. F Chiti, CM Dobson, Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade. Annu. Rev. Biochem. 86, 27–68 (2017). 6. TPJ Knowles, MJ Buehler, Nanomechanics of functional and pathological amyloid materials. Nat. Nanotechnol. 6, 469–479 (2011). 7. I Cherny, E Gazit, Amyloids: Not Only Pathological Agents but Also Ordered Nanomaterials. Angewandte Chemie Int. Ed. 47, 4062–4069 (2008). 8. G Wei, et al., Self-assembling peptide and protein amyloids: From structure to tailored function in nanotechnology. Chem. Soc. Rev. 46, 4661–4708 (2017). 9. C Li, R Qin, R Liu, S Miao, P Yang, Functional amyloid materials at surfaces/interfaces. Biomater. Sci. 6, 462–472 (2018). 10. LD Koh, et al., Structures, mechanical properties and applications of silk fibroin materials. Prog. Polym. Sci. 46, 86–110 (2015). 11. DH De Oliveira, et al., Structural conversion of the spidroin C-terminal domain during assembly of spider silk fibers. Nat. Commun. 15, 1–14 (2024). 12. A Kamada, et al., Controlled self-assembly of plant proteins into high-performance multifunctional nanostructured films. Nat. Commun. 12, 3529 (2021). 13. P Arosio, M Vendruscolo, CM Dobson, TPJ Knowles, Chemical kinetics for drug discovery to combat protein aggregation diseases. Trends Pharmacol. Sci. 35, 127–135 (2014). 14. SIA Cohen, et al., A molecular chaperone breaks the catalytic cycle that generates toxic Aβ oligomers. Nat. Struct. & Mol. Biol. 22, 207–213 (2015). 15. G Meisl, TPJ Knowles, D Klenerman, Mechanistic Models of Protein Aggregation Across Length-Scales and Time-Scales: From the Test Tube to Neurodegenerative Disease. Front. Neurosci. 16 (2022). 16. BH Kim, et al., Second-generation anti-amyloid monoclonal antibodies for Alzheimer's disease: Current landscape and future perspectives. Transl. Neurodegener. 14, 6 (2025). 17. N Sehra, R Parmar, R Jain, Peptide-based amyloid-beta aggregation inhibitors. RSC Medicinal Chem. 16, 1083–1104 (2025). 18. E Hellstrand, B Boland, DM Walsh, S Linse, Amyloid β-Protein Aggregation Produces Highly Reproducible Kinetic Data and Occurs by a Two-Phase Process. ACS Chem. Neurosci. 1, 13–18 (2010). 19. TCT Michaels, et al., Amyloid formation as a protein phase transition. Nat. Rev. Phys. 5, 379–397 (2023). 20. A Buell, Stability matters, too - The thermodynamics of amyloid fibril formation. Chem. Sci. 13 (2022). 21. Y Goto, M Noji, K Nakajima, K Yamaguchi, Supersaturation-Dependent Formation of Amyloid Fibrils. Molecules 27, 4588 (2022). 22. M Lindberg, J Hu, E Sparr, S Linse, Reduced protein solubility – cause or consequence in amyloid disease? QRB Discov. 6, e8 (2025). 23. F Mahmoudinobar, JM Urban, Z Su, BL Nilsson, CL Dias, Thermodynamic Stability of Polar and Nonpolar Amyloid Fibrils. J. Chem. Theory Comput. 15, 3868–3874 (2019). 24. K Imahori, T Uchida, Physiology and pathology of tau protein kinases in relation to Alzheimer's disease. J. Biochem. 121, 179–188 (1997). 25. M P ´erez, R Cuadros, MA Smith, G Perry, J Avila, Phosphorylated, but not native, tau protein assembles following reaction with the lipid peroxidation product, 4-hydroxy-2-nonenal. FEBS Lett. 486, 270–274 (2000). 26. T P ´almad ´ottir, A Malmendal, T Leiding, M Lund, S Linse, Charge Regulation during Amyloid Formation of α-Synuclein. J. Am. Chem. Soc. 143, 7777–7791 (2021). 27. MR Sawaya, MP Hughes, JA Rodriguez, R Riek, DS Eisenberg, The Expanding Amyloid Family: Structure, Stability, Function, and Pathogenesis. Cell 184, 4857–4873 (2021). 28. MT Colvin, et al., Atomic Resolution Structure of Monomorphic Aβ42 Amyloid Fibrils. J. Am. Chem. Soc. 138, 9663–9674 (2016). 29. JHM van Gils, et al., The hydrophobic effect characterises the thermodynamic signature of amyloid fibril growth. PLOS Comput. Biol. 16, e1007767 (2020). 30. CL Dias, et al., The hydrophobic effect and its role in cold denaturation. Cryobiology 60, 91–99 (2010). 31. T Urbic, CL Dias, Thermodynamic properties of amyloid fibrils: A simple model of peptide aggregation. Fluid Phase Equilibria 489, 104–110 (2019). 32. T P ´almad ´ottir, et al., On the reversibility of amyloid fibril formation. Biophys. Rev. 6, 011303 (2025). 33. NT Southall, KA Dill, ADJ Haymet, A View of the Hydrophobic Effect. The J. Phys. Chem. B 106, 521–533 (2002). 34. R Stephenson, J Stuart, M Tabak, Mutual solubility of water and aliphatic alcohols. J. Chem. & Eng. Data 29, 287–290 (1984). 35. T Ikenoue, et al., Cold Denaturation of α-Synuclein Amyloid Fibrils. Angewandte Chemie 126, 7933–7938 (2014). 36. M Noji, et al., Breakdown of supersaturation barrier links protein folding to amyloid formation. Commun. Biol. 4, 120 (2021). 37. AN Naganathan, Chapter 1 - Protein folding: How, why, and beyond in Protein Homeostasis Diseases, ed. AL Pey. (Academic Press), pp. 3–22 (2020). 38. K Sasahara, H Naiki, Y Goto, Kinetically Controlled Thermal Response of β2-Microglobulin Amyloid Fibrils. J. Mol. Biol. 352, 700–711 (2005). 39. HA Miers, F Isaac, XLVII.—The refractive indices of crystallising solutions, with especial reference to the passage from the metastable to the labile condition. J. Chem. Soc. Transactions 89, 413–454 (1906). 40. JW Mullin, Crystallization. (Elsevier Science & Technology, Oxford), 4th ed edition, (2001). 41. V Lattanzi, K Bernfur, E Sparr, U Olsson, S Linse, Solubility of Aβ40 peptide. JCIS Open 4, 100024 (2021). 42. M Lindberg, E Axell, E Sparr, S Linse, A label-free high-throughput protein solubility assay and its application to Aβ40. Biophys. Chem. 307, 107165 (2024). 43. R Cukalevski, et al., The Aβ40 and Aβ42 peptides self-assemble into separate homomolecular fibrils in binary mixtures but cross-react during primary nucleation. Chem. Sci. 6 (2015). 44. J Danielsson, J Jarvet, P Damberg, A Gr ¨aslund, The Alzheimer β-peptide shows temperature-dependent transitions between left-handed 31-helix, β-strand and random coil secondary structures. The FEBS J. 272, 3938–3949 (2005) eprint: https://febs.onlinelibrary.wiley.com/doi/pdf/10.1111/j.1742-4658.2005.04812.x. 45. J Jarvet, et al., A left-handed 31 helical conformation in the Alzheimer Aβ(12–28) peptide. FEBS Lett. 555, 371–374 (2003) eprint: https://febs.onlinelibrary.wiley.com/doi/pdf/10.1016/S0014-5793%2803%2901293-6. 46. NN Khechinashvili, J Janin, F Rodier, Thermodynamics of the temperature-induced unfolding of globular proteins. Protein Sci. 4, 1315–1324 (1995) eprint: https://onlinelibrary.wiley.com/doi/pdf/10.1002/pro.5560040707. 47. GI Makhatadze, PL Privalov, Energetics of Protein Structure in Advances in Protein Chemistry. (Elsevier) Vol. 47, pp. 307–425 (1995). 48. PL Privalov, GI Makhatadze, Heat capacity of proteins: II. Partial molar heat capacity of the unfolded polypeptide chain of proteins: Protein unfolding effects. J. Mol. Biol. 213, 385–391 (1990). 49. TO Mason, et al., Thermodynamics of Polypeptide Supramolecular Assembly in the Short-Chain Limit. J. Am. Chem. Soc. 139, 16134–16142 (2017). 50. J Kardos, K Yamamoto, K Hasegawa, H Naiki, Y Goto, Direct Measurement of the Thermodynamic Parameters of Amyloid Formation by Isothermal Titration Calorimetry*. J. Biol. Chem. 279, 55308–55314 (2004). 51. SIA Cohen, et al., Distinct thermodynamic signature of oligomer generation in the aggregation of the amyloid-β peptide. Nat. chemistry 10, 523–531 (2018). 52. FW Studier, Protein production by auto-induction in high-density shaking cultures. Protein Expr. Purif. 41, 207–234 (2005). 53. DM Walsh, et al., A facile method for expression and purification of the Alzheimer's disease-associated amyloid β-peptide. The FEBS J. 276, 1266–1281 (2009). 54. S Linse, Expression and Purification of Intrinsically Disordered Aβ Peptide and Setup of Reproducible Aggregation Kinetics Experiment in Intrinsically Disordered Proteins: Methods and Protocols, Methods in Molecular Biology, eds. BB Kragelund, K Skriver. (Springer US, New York, NY), pp. 731–754 (2020)